23andMe to slash 40% of its workforce, end therapeutics program to cut costs



23andMe to slash 40% of its workforce, end therapeutics program to cut costs


  • Related Posts

    Dow ends 4-day losing streak as stocks finish mixed ahead of Nvidia earnings

    U.S. stocks finished mixed Wednesday after choppy trading as investors braced for a key earnings report from AI chipmaker Nvidia Corp. after the closing bell. The Dow Jones Industrial Average…

    Read more

    DOJ pushes for Google to abandon Chrome browser after antitrust case

    Assistant U.S. Attorney General Jonathan Kanter speaks about the antitrust lawsuit against Live Nation Entertainment at a news conference as Attorney General Merrick Garland and Assistant Attorney General Lisa O.…

    Read more